MedPath

Hyaluronic Acid Delivery: CO2 Laser Versus Thulium Laser Treatment

Not Applicable
Recruiting
Conditions
Aging Skin
Interventions
Other: CO2 laser + HA
Other: Thulium laser + HA
Registration Number
NCT06431282
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Brief Summary

* Weakly crossed-linked hyaluronic acid (HA) can be delivered through multiple injections into the dermal and subnormal layer to improve skin quality. However, this treatment comes with multiple bumps for several days.

* Alternatively, HA can be delivered after CO2 laser or thulium laser pretreatment. As microscopic analysis after this treatment is limited, the object of the present study is to investigate the morphological cellular changes after CO2 laser and thulium laser delivered HA into human skin.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • healthy male and female patients
Exclusion Criteria
  • pregnancy, breast feeding
  • open wounds at the area to be treated

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CO2 laser + HACO2 laser + HAProbands are treated with a CO2 laser. Afterwards a HA gel will be applied.
Thulium laser + HAThulium laser + HAProbands are treated with a thulium laser. Afterwards a HA gel will be applied.
Primary Outcome Measures
NameTimeMethod
Size of keratinocytes30 minutes and 30 days after treatment.

Size of keratinocytes after CO2 or thulium laser treatment compared to control.

Size of hyaluronic acid granules30 minutes and 30 days after treatment.

Size of HA granules after CO2 or thulium laser treatment compared to control.

Size of intercellular spaces30 minutes and 30 days after treatment.

Size of intercellular spaces after CO2 or thulium laser treatment compared to control.

Distribution of Hyaluronic Acid30 minutes and 30 days after treatment.

Distribution though the epidermal and dermal layers after CO2 or thulium laser treatment compared to control.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Medical-Center Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath